OpenAI Secures $110 Billion Funding Round at $840 Billion Valuation Ahead of IPO 
Gold Prices Surge Over 2% After U.S.-Israel Strikes on Iran Spark Safe-Haven Demand 
Gold Prices Surge for Fourth Day as Middle East Tensions and Strong U.S. Dollar Shape Market 
Flare, Xaman Roll Out One-Click DeFi Vault for XRP Yield via XRPL Wallets 
FAA Plans Flight Reductions at Chicago O’Hare as Airlines Ramp Up Summer Schedules 
Fitch Downgrades Paramount Skydance and Paramount Global to Junk Amid Warner Bros Discovery Deal Concerns 
Dollar Rallies as Middle East Conflict Weighs on Yen and Euro, Lifts Safe-Haven Demand 
Australian Job Advertisements Hit 16-Month High as Labour Market Stays Resilient 
China’s New Home Prices Post Sharpest Drop Since 2022 Amid Ongoing Property Slump 
AWS Data Center in UAE Hit by Fire After Objects Strike Facility Amid Regional Tensions 
Australia Housing Market Hits Record High Despite RBA Rate Hike 
MOEX Russia Index Hits 3-Month High as Energy Stocks Lead Gains 
Global Markets React as Dollar Surges, Swiss Franc Rallies After U.S.-Israel Strike on Iran 
FedEx Faces Class Action Lawsuit Over Tariff Refunds After Supreme Court Ruling 
Rio Tinto Advances Gallium Extraction Project in Canada with Federal Funding Support 
Oil Prices Surge 13% as U.S.-Israel Strikes on Iran Spark Supply Fears 
Samsung Electronics Stock Poised for $1 Trillion Valuation Amid AI and Memory Boom 
Namyang Dairy saw a surge in its shares after claiming its Bulgaris yogurt variants can help lower the risk of COVID-19 infection. The company's day trading on Wednesday, April 14, reportedly increased.
As per The Korea Herald, Namyang Dairy’s shares once shot up by 28.68% to KRW489,000 or around $437.39 in the early morning trading. It was added that within 20 minutes after the opening bell, the company’s preferred stocks also surge by the daily allowable limit of 29.78% to reach KRW231,000.
Prior to Wednesday’s results, it was reported that the firm’s shares went up 7.19% and 6.71% on Friday and Monday, respectively. It then increased again by 8.57% on Tuesday, and this shows that Namyang Dairy’s shares have been on the rise since last weekend and continued this week.
Namyang’s COVID-19 claim
Observers are saying that the company’s surge in shares may be due to its claims that its Bulgaris yogurt lineup can help reduce the risk of getting COVID-19. Some market insiders also think that some investors may have also used information that caused the hike in the recent stock tradings.
At any rate, what triggered the sudden increase in shares of Namyang Dairy was the statement given by the company during a news conference in Seoul.
“We’re the first firm in the country that has discovered fermented dairy products are effective in preventing influenza and COVID-19 viruses,” Namyang’s chief of antiviral immune research center, Park Jong Su, said at that time. “Our experiments showed that Bulgaris helped remove the Influenza A (H1N1) virus at a 99.999 percent rate of success, and the COVID-19 at a 77.8 percent success rate.”
He added that the test of the yogurt’s effectiveness in fighting coronavirus was done using the lung cells of a monkey. As a result of this claim, people reportedly rushed out to purchase Namyang Dairy’s Bulgaris yogurts in stores.
Statement from S. Korea’s health officials
After the announcement from Namyang, the public health authorities released a statement. The agency expressed its concern over the claims.
“The latest research result has not proved to be effective in eliminating those viruses in the human body,” the Korea Disease Control and Prevention Agency stated. “Therefore, it is hard to say whether it can serve as an actual prevention or treatment measure for (the viruses).”
